Evaluating Roivant Sciences: Insights From 6 Financial Analysts

Roivant Sciences (NASDAQ:ROIV) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise overview o

BenzingaJun 18 23:00

Cantor Fitzgerald Reiterates Overweight on Roivant Sciences

Cantor Fitzgerald analyst Louise Chen reiterates Roivant Sciences (NASDAQ:ROIV) with a Overweight.

BenzingaJun 18 22:07

Roivant Sciences' (NASDAQ:ROIV) Performance Raises Some Questions

Even though Roivant Sciences Ltd. (NASDAQ:ROIV) posted strong earnings recently, the stock hasn't reacted in a large way. We decided to have a deeper look, and we believe that investors might be worr

Simply Wall StJun 6 19:41

Buy Rating Justified by Roivant Sciences' Growth Prospects and Strategic Pipeline Expansion

TipRanksMay 31 22:05

Piper Sandler Keeps Their Buy Rating on Roivant Sciences (ROIV)

TipRanksMay 31 19:05

HC Wainwright & Co. : The Roivant Sciences (ROIV.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $18.00 to $18.00.

HC Wainwright & Co. : The Roivant Sciences (ROIV.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $18.00 to $18.00.

Zhitong FinanceMay 31 18:41